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Abstract
Background: Loss-of-function mutations of human cardiac sodium channel gene SCN5A induce a wide range of
arrhythmic disorders. Mutation carriers with co-existing conditions such as congenital heart diseases and histories of
cardiac surgeries, could develop complex arrhythmic events that are difficult to diagnose.
Case presentation: A 41-year-old Japanese male with a history of a surgical closure of an ASD presented
impairment of consciousness by wide QRS tachycardia. Because the patient’s baseline ECG in sinus rhythm showed
similar QRS axis with right bundle brunch block morphology, we suspected supraventricular tachycardia (SVT).
During hospitalization, the patient developed polymorphic ventricular tachycardia that was induced by bradycardia.
In an electrophysiological study, the SVT was identified as right atrial incisional tachycardia circulating around the
scar in the right atrium.
The genetic analysis revealed a heterozygous SCN5A c.4037–4038 del TC, p. L1346HfsX38 variant. We diagnosed this
patient as having progressive cardiac conduction disorder (PCCD) and polymorphic VT caused by the mutation.
Incisional tachycardia with wide QRS morphology was a by-standing comorbidity related to the history of cardiac
surgery which could miss lead the diagnosis.
The patient’s SVT was eliminated by radiofrequency catheter ablation. An implantable cardioverter defibrillator (ICD)
was implanted for the secondary prevention of polymorphic VT. Cardiac pace-making therapy by the ICD to avoid
bradycardia effectively suppressed the patient’s arrhythmic events.
Conclusions: We treated a patient with a sodium channel gene variant. Co-existing SVT originated by a scar in the
right atrium made the diagnosis extremely difficult. A multilateral diagnostic approach using an ECG analysis, an
electrophysiological study, and genetic screening enabled effective combination therapy comprised of catheter
ablation and an ICD.
Keywords: Case report, SCN5A, Ventricular fibrillation, Postoperative supraventricular tachycardia, Brugada
syndrome, Cardiac conduction defect, Atrial septal defect
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Background
Loss-of-function variants of human cardiac sodium
channel gene SCN5A induce a wide range of arrhythmic
disorders, such as Brugada syndrome [1, 2], dilated car-
diomyopathy [3], and progressive cardiac conduction
disorder (PCCD, also known as Lev-Lenègre syndrome)
[4], which are known as sodium channelopathies.
Surgical closure for an atrial septal defect (ASD) is a
well-established procedure with a good long-term out-
come [5–8]. However, postoperative supraventricular
tachycardia is a frequent sequela among ASD patients
treated by surgical closure [6, 8].
Here we report the case of a patient with a multiple
arrhythmia who carried an SCN5A frameshift mutation
with a surgical repair history for ASD. We provide the
details of the pathology of this complex case toward to
goal of devising a better therapeutic approach.
Case presentation
Initial tachycardia attack in a case with a history of
cardiac surgery
A 41-year-old Japanese male presented impairment of
consciousness by wide QRS tachycardia (Fig. 1a).
Although his systolic blood pressure has been kept around
60–70mmHg during the tachycardia, his conscious level
was moderately impaired to E1V2M4 in the Glasgow
Coma Scale. At his arrival at a hospital, he was immedi-
ately sedated and intubated by emergency physicians who
assessed his condition as a cardiogenic shock. The tachy-
cardia self-terminated soon after the administration of the
sedative. He had a history of a surgical closure of an ASD
at 20 years old. After that surgery ~ 20 years earlier, his
QRS interval had gradually increased to 198ms, and in
the 2 years prior to his presentation at our hospital, right
bundle brunch block morphology became evident (Fig.
1b). Because the QRS axis of the tachycardia matched that
of sinus rhythm, we suspected supraventricular tachycar-
dia (SVT). After the initial assessment, we decided to ob-
serve his condition overnight in an intensive care unit
under the sedated and intubated condition.
In-hospital event
In the intensive care unit, his sinus bradycardia seriously
worsened during that night while he was under sedation,
and he developed polymorphic ventricular tachycardia
(VT) followed by ventricular fibrillation (Fig. 2) which
Fig. 1 Initial tachycardia attack and the time-dependent progression of cardiac conduction defect in the patient, a 41-year-old male. a 12-lead
ECGs of the first tachycardia event and the sinus rhythm. b ECGs recorded 20 years after the patient’s ASD closure
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required a cardioversion. As a marked sinus bradycardia
continued, transcutaneous ventricular pacing was initi-
ated, which increased his heart rate and successfully sup-
pressed the recurrence of ventricular tachycardia. We
considered that this arrhythmia was not identical with
that observed in the initial event where the QRS morph-
ology was stable and the blood pressure was kept above
60mmHg. During these arrhythmic events, no pro-
longed QTc interval was recorded.
Electrophysiological study for the patient’s SVT, and
treatment
In an electrophysiological study, programmed electrical
stimulation (PES) from the right ventricle easily induced
polymorphic ventricular tachycardia that sustained and
degradated to ventricular fibrillation. Sustained mono-
morphic VT was never induced during the study. The pa-
tient’s SVT was identified as right atrial incisional
tachycardia circulating around the scar in the right atrium
(Fig. 3). The post-pacing interval at the upper end of the
scar matched the tachycardia cycle length (Fig. 3a, b, left
panel). At this site, radiofrequency catheter ablation suc-
cessfully terminated the tachycardia (Fig. 3b, right).
To prevent sudden death by further attacks of ventricular
fibrillation, the patient underwent implantable cardioverter-
defibrillator (ICD) implantation. His bradycardia was
treated by the pace-making therapy afforded by the ICD.
Under an 80-bpm DDD-pacing condition, his heart beat
was fully paced, and the polymorphic ventricular tachycar-
dia was successfully suppressed. During 18months’ follow-
up, he has never experienced further arrhythmic events and
there were no adverse events related to interventions he re-
ceived. He returned to work as before, and is satisfied with
the treatment results he received.
Genetic analysis
The patient’s severe sinus bradycardia, progressive QRS
widening, high voltage amplitude of R’ wave in the right
precordial leads, and recurrent ventricular arrhythmias in-
dicated that the patient had cardiac sodium channelopathy
like PCCD and Brugada syndrome. We then performed
genetic screening for inherited arrhythmias by targeted
gene sequencing. The genetic analysis revealed a heterozy-
gous SCN5A c.4037–4038 del TC, p. L1346HfsX38 variant
(Fig. 4). The 2-bp deletion in exon 23 of SCN5A induced
the truncation of mRNA, leading to nonsense-mediated
mRNA decay (NMD), and thereby decreasing the expres-
sion level of the cardiac sodium channel Nav1.5. The same
variant was also detected in the genomic DNA from the pa-
tient’s asymptomatic mother. Her ECG manifested only
mild QRS widening with 130ms QRS interval and slight
sinus bradycardia (HR 50-56 bpm). This variant had not
been reported in large genomic databases such as gnomAD
(https://gnomad.broadinstitute.org) and TOGOVAR
(https://togovar.biosciencedbc.jp/).
In the American College of Medical Genetics and
Genomics (ACMG) guideline, this variant is classified as
“likely pathogenic” with one PVS1 (null variant) and one
PM2 (not observed in population databases).
We diagnosed this patient as having a PCCD and poly-
morphic ventricular tachycardia due to the SCN5A loss-of-
function variant. Postoperative SVT with wide QRS morph-
ology was a by-standing comorbidity related to the history
of cardiac surgery which could miss lead the diagnosis.
Discussion and conclusions
We presented a patient with a heterozygous SCN5A frame-
shift variant and a history of a surgical ASD closure. The
identified variant, p. L1346HfsX38, was not reported previ-
ously. Because the frameshift variant was in exon 23 of
SCN5A, which normally consists of 28 exons, we suspected
that the variant caused a truncation of mRNA, resulting in
the decreased expression level of Nav1.5 due to NMD [9].
The patient’s sinus bradycardia, cardiac conduction disturb-
ance with severe QRS widening, and ventricular fibrillation
were all compatible as phenotypes of Brugada syndrome
[10]. However, type 1 Brugada ECG findings were not evi-
dent because of the patient’s complete right bundle brunch
block. The fact that the patient’s mother also carried the
same variant but remained asymptomatic was not
Fig. 2 ECGs recorded during hospitalization. Sinus bradycardia and subsequent polymorphic ventricular tachycardia recorded under sedation
(left). The polymorphic ventricular tachycardia which required a cardioversion (right)
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surprising, because 90% of Brugada syndrome patients are
male [10, 11].
In the last decade, the concept that sodium channelopa-
thies are not pure arrhythmogenic disorders but rather are
cardiomyopathies with a strong arrhythmogenesis has
been widely accepted. An association between these
variants and congenital structural heart diseases has
not been demonstrated. In our patient’s case, we
could not conclude that the patient’s ASD was caused
by his SCN5A variant.
Trans-catheter ASD closure with a device has gained ac-
ceptance, but surgical closure remains the first-line strategy
with excellent long-term outcomes [8]. Sinus node dysfunc-
tion requiring a pacemaker implantation was reported in
approx. 4% of patients after a surgical ASD closure in a
long-term follow-up study [12], but severe QRS widening,
bundle brunch blocks, and life-threatening ventricular ar-
rhythmias are extremely rare. In our patient’s case, the
sinus bradycardia had worsened during 20 years after his
ASD surgery, and complete right bundle brunch block with
severe QRS widening was observed as well. This drastic
change was not plausible as a late complication of surgical
repair for ASD.
Postoperative SVT is commonly seen after a cardiac
surgery; not only for ASD repair, but for all types of con-
genital heart disease [13]. Our patient’s arrhythmia was
observed to be circulating around the incision in the
right atrium (which is known as incisional tachycardia),
and radiofrequency ablation at the top of the incision
successfully eliminated the arrhythmia. Due to the im-
paired cardiac conduction by an SCN5A variant, this
often-observed arrhythmia presented a rare clinical
manifestation that was initially difficult to interpret.
The sedation in the intensive care unit possibly triggered
his polymorphic VT by worsening bradycardia. However,
considering the rapid progression of CCD in the last 2
years, we are convinced that he would have the similar ad-
verse event in very near future even without sedation.
When it comes to the choice of implantable cardiac de-
vice, although this patient’s polymorphic VT was success-
fully suppressed by controlling bradycardia, we chose ICD
rather than simple DDD pacemaker. It is because of the
Fig. 3 Electrophysiological study. a The right anterior oblique (RAO) and left anterior oblique (LAO) projections showing the electrode positions. The ABL electrode
is at the upper edge of the scar in the right atrium. b The post-pacing interval from the ABL electrode at the upper edge of the scar matched the cycle length of
the tachycardia (left). Arrows indicate the 280-ms burst pacing from the ABL electrode. Radiofrequency ablation promptly terminated the tachycardia (right)
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high inducibility of polymorphic VT by PES from the right
ventricle. PES-induced ventricular tachycardia is one of
the predictors of lethal events of Brugada syndrome [14]
even though there is still a controversy [15]. We con-
cluded that ICD implantation was not an overtreatment
for this patient’s case.
Currently, 97% of the patient’s heart beats are stimulated
by dual chamber pacing by the ICD. At the time of im-
plantation, we did not expect that a setting preferring pa-
tient’s intrinsic ventricular beats had a significant advantage
over right ventricular stimulation for cardiac synchronicity
because his own QRS was extremely widened. However,
considering his age, it is also necessary to optimize the
pacemaker setting by assessing hemodynamics with or
without right ventricular pacing, as well as preventing
bradycardia.
As a differential diagnosis, arrhythmogenic right ven-
tricular cardiomyopathy and bundle branch reentry VT
can be stated. But cardiac magnetic resonance imaging
could not detect late gadolinium-enhancement in either
left or right ventricular cardiac muscle. Sustained mono-
morphic VT, which was suggesting bundle brunch VT,
could not be induced by repetitive PES. Furthermore, we
detected no genetic variant in desmosomal genes, typical
ARVC causative genes.
In conclusion, multiple coexisting arrhythmogenicities
induced repetitive arrhythmias difficult to diagnose in
our patient with a sodium channelopathy. A precise un-
derstanding of this patient’s pathology by a multilateral
approach using an ECG analysis, an electrophysiological
study, and genetic screening enabled effective combin-
ation therapy comprised of catheter ablation and an
ICD.
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